Development of an in-vivo active reversible butyrylcholinesterase inhibitor.
Košak U, Brus B, Knez D, Šink R, Žakelj S, Trontelj J, Pišlar A, Šlenc J, Gobec M, Živin M, Tratnjek L, Perše M, Sałat K, Podkowa A, Filipek B, Nachon F, Brazzolotto X, Więckowska A, Malawska B, Stojan J, Raščan IM, Kos J, Coquelle N, Colletier JP, Gobec S.
Košak U, et al. Among authors: zakelj s.
Sci Rep. 2016 Dec 21;6:39495. doi: 10.1038/srep39495.
Sci Rep. 2016.
PMID: 28000737
Free PMC article.